sizofiran has been researched along with Uterine Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimizu, Y | 1 |
Chen, JT; Hasumi, K; Masubuchi, K; Shimizu, Y; Suzuki, M; Teshima, H | 1 |
Date, Y; Iwanari, O; Kijima, S; Kitao, M; Miyako, J; Moriyama, M; Ryuko, K; Yoshino, N | 1 |
1 review(s) available for sizofiran and Uterine Neoplasms
Article | Year |
---|---|
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combinations; Female; Genital Neoplasms, Female; Humans; Japan; Multicenter Studies as Topic; Ovarian Neoplasms; Sizofiran; Survival Analysis; Tegafur; Uracil; Uterine Neoplasms | 2002 |
2 other study(ies) available for sizofiran and Uterine Neoplasms
Article | Year |
---|---|
[Sizofiran and recombinant interferon gamma stimulate peritoneal macrophages obtained from patients with gynecologic malignancies--increased secretion of tumor necrosis factor, IL-1 and interferon-gamma].
Topics: Dinoprostone; Female; Glycosaminoglycans; Humans; Interferon-gamma; Interleukin-1; Macrophage Activation; Ovarian Neoplasms; Peritoneal Cavity; Recombinant Proteins; Sizofiran; Tumor Necrosis Factor-alpha; Uterine Neoplasms | 1990 |
[The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation].
Topics: Adult; Aged; Combined Modality Therapy; Female; Glycosaminoglycans; Humans; Middle Aged; Sizofiran; Uterine Neoplasms | 1989 |